Demonstration Formulary
5 Infections
This formulary indicates prescribing status only, for guidance on managing infections please refer to your local antibiotic guidelines
Summary of antimicrobial prescribing guidance - managing common infections
05-01-12 Quinolones
| Ciprofloxacin |
|
Formulary
|
 Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects |
|
| Ciprofloxacin |
|
Formulary
|
|
Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects |
|
| Levofloxacin |
|
Formulary
|
|
|
Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects |
|
|
| Levofloxacin |
|
Formulary
|
|
Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects |
|
|
| Moxifloxacin |
|
Formulary
|
Hospital use only under microbiological advice |
|
Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects |
|
|
| Norfloxacin |
|
Formulary
|
Hospital use only under microbiological advice |
|
Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects |
|
|
| Ofloxacin |
|
Formulary
|
Hospital use only under microbiological advice /GUM |
|
Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects |
|
|
Links
- Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects
- Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects
- Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects
- Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects
- Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects
- Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects
- Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects
- NICE NG15: Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use
- NICE NG199: Clostridioides difficile infection: antimicrobial prescribing
- NICE NG79: Sinusitis (acute): antimicrobial prescribing
- NICE NG79: Sinusitis (acute): antimicrobial prescribing (visual summary)
Summary of antimicrobial prescribing guidance - managing common infections